R Stasi

Summary

Country: Italy

Publications

  1. ncbi Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Br J Haematol 105:141-8. 1999
  2. ncbi AML-M0: a review of laboratory features and proposal of new diagnostic criteria
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Blood Cells Mol Dis 25:120-9. 1999
  3. ncbi Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Via S Francesco 50, 00041 Albano Laziale, Italy
    Blood Cells Mol Dis 26:582-6. 2000
  4. ncbi Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Blood 98:952-7. 2001
  5. ncbi Response to recombinant human erythropoietin in patients with myelodysplastic syndromes
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, 00041 Albano Laziale, Italy
    Clin Cancer Res 3:733-9. 1997
  6. ncbi Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Via San Francesco, 50, 00041 Albano Laziale, Italy
    Rheumatology (Oxford) 45:1432-6. 2006
  7. ncbi Once-weekly dosing of recombinant human erythropoietin alpha in patients with myelodysplastic syndromes unresponsive to conventional dosing
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Ann Oncol 15:1684-90. 2004
  8. ncbi Darbepoetin alfa for the treatment of anemic patients with low- and intermediate-1-risk myelodysplastic syndromes
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Ann Oncol 16:1921-7. 2005
  9. ncbi Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Am J Med Sci 315:237-41. 1998

Detail Information

Publications9

  1. ncbi Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Br J Haematol 105:141-8. 1999
    ..However, in vivo synergy between these growth factors for the production of erythroid precursors is not supported by our data...
  2. ncbi AML-M0: a review of laboratory features and proposal of new diagnostic criteria
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Blood Cells Mol Dis 25:120-9. 1999
    ..In this article we review the laboratory data acquired from various sources and suggest a partial modification of diagnostic criteria...
  3. ncbi Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Via S Francesco 50, 00041 Albano Laziale, Italy
    Blood Cells Mol Dis 26:582-6. 2000
    ..We conclude that high-dose DXM has a limited effect in patients with chronic ITP. Novel approaches and controlled multicenter trials may help identify new therapeutic strategies for this disease...
  4. ncbi Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Blood 98:952-7. 2001
    ..In view of its mild toxicity and the lack of effective alternative treatments, its use in the setting of chronic refractory ITP is warranted. (Blood. 2001;98:952-957)..
  5. ncbi Response to recombinant human erythropoietin in patients with myelodysplastic syndromes
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, 00041 Albano Laziale, Italy
    Clin Cancer Res 3:733-9. 1997
    ..These data suggest that rhEPO has a role in the treatment of certain patients with MDS, particularly in those with a high erythroid index and detectable circulating erythroid burst-forming units...
  6. ncbi Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Via San Francesco, 50, 00041 Albano Laziale, Italy
    Rheumatology (Oxford) 45:1432-6. 2006
    ..We prospectively studied the long-term effects of rituximab in 10 patients with anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis refractory to conventional therapy (n=3) or in second or subsequent relapse (n=7)...
  7. ncbi Once-weekly dosing of recombinant human erythropoietin alpha in patients with myelodysplastic syndromes unresponsive to conventional dosing
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Ann Oncol 15:1684-90. 2004
    ..We performed a clinical trial to evaluate the effects of this new dosing regimen in patients with MDS who were unresponsive to the conventional three-times-weekly schedule...
  8. ncbi Darbepoetin alfa for the treatment of anemic patients with low- and intermediate-1-risk myelodysplastic syndromes
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Ann Oncol 16:1921-7. 2005
    ..The hematological and quality of life (QoL) changes associated with darbepoetin alfa (DA) therapy were assessed in anemic patients with previously untreated low- and intermediate-1-risk myelodysplastic syndrome (MDS)...
  9. ncbi Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera
    R Stasi
    Department of Medical Sciences, Regina Apostolorum Hospital, Albano Laziale, Italy
    Am J Med Sci 315:237-41. 1998
    ..We conclude that subcutaneous human leukocyte interferon-alpha is an effective and well-tolerated therapy in the management of polycythemia vera-associated myeloproliferation and pruritus in patients less than 60 years old...